As NPS have entered the markets at an unprecedented rate, legislation has been unable to keep pace. This report for policymakers and legal practioners, from the EMCDDA and Eurojust, aims to outline the challenges and paths forward in NPS regulation.
HRI release their biennial report, discussing drug-related HIV, viral hepatitis and tuberculosis. It also integrates updated information on harm reduction services, including on needle and syringe programmes and opioid substitution therapy.
Prisons are in crisis with record levels of suicides, violence and self-harm. Spurred on by synthetic cannabinoids, 8% of men in prison in England and Wales report developing a drug problem since they have been in prison. In prisons with the worst regimes this is as high as 16%.
The conference brought together an array of international policy makers to focus on two primary issues; the growing significance of the internet as a platform for illicit drug transactions and the increasing use of synthetic drugs.